Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trial. - Ravaud, A.; Trufflandier, N.; Ferrière, J.M.; Debled, M.; Palussière, J.; Cany, L.; Gaston, R.; Mathoulin-Pélissier, S.; Bui, B.N.; Ferrière, J M; Palussière, J; Mathoulin-Pélissier, S (British Journal of Cancer, 2003)